Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Head & Neck 1

Conditions

Breast Neoplasms 60Head and Neck Neoplasms 22Squamous Cell Carcinoma of Head and Neck 21Lung Neoplasms 20Carcinoma, Non-Small-Cell Lung 20Colorectal Neoplasms 19Melanoma 17Colonic Neoplasms 16Rectal Neoplasms 15Carcinoma, Renal Cell 13Pancreatic Neoplasms 12Lymphoma 12Prostatic Neoplasms 11Ovarian Neoplasms 11Lymphoma, Follicular 11Carcinoma, Ovarian Epithelial 11Kidney Neoplasms 9Breast Neoplasms, Male 9Salivary Gland Neoplasms 8Lymphoma, Large B-Cell, Diffuse 8Central Nervous System Neoplasms 8Sarcoma 7Liver Neoplasms 7Esophageal Neoplasms 7Uterine Cervical Neoplasms 6Urinary Bladder Neoplasms 6Unspecified Adult Solid Tumor, Protocol Specific 6Neuroblastoma 6Lymphoma, Large-Cell, Anaplastic 6Lymphoma, B-Cell, Marginal Zone 6

Interventions

Cisplatin 5Platinum 4Cetuximab 41,2-diaminocyclohexaneplatinum II citrate 4Carboplatin 3Radiotherapy, Intensity-Modulated 2Nivolumab 2Immunoglobulin G 2Gemcitabine 2Gefitinib 2Fluorouracil 2Docetaxel 2Disulfides 2Biopsy 2Bevacizumab 2vandetanib 1temsirolimus 1linrodostat 1ficlatuzumab 1durvalumab 1dl1520 1dehydroftorafur 1cediranib 1atezolizumab 1adavosertib 1X-Rays 1Trioxsalen 1Specimen Handling 1Soybean Proteins 1Sirolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoid Interstitial Pneumonia × Immunohistochemistry × Clear all
NCT01414426 2021-01-14

Vandetanib in Preventing Head and Neck Cancer in Patients With Precancerous Head and Neck Lesions

University of Chicago

Phase 2 Completed
20 enrolled 7 charts
Head & NeckOther neoplasm

Lymphoid Interstitial Pneumonia, Squamous Cell Carcinoma of Head and Neck, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡